News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
152,139 Results
Type
Article (8388)
Company Profile (41)
Press Release (143710)
Multimedia
Podcasts (6)
Webinars (2)
Section
Business (45588)
Career Advice (143)
Deals (8006)
Drug Delivery (32)
Drug Development (20740)
Employer Resources (12)
FDA (4399)
Job Trends (2708)
News (80351)
Policy (8973)
Tag
2024 BioForest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
Academia (503)
Accelerated approval (3)
Adcomms (7)
Allergies (34)
Alliances (15682)
ALS (17)
Alzheimer's disease (344)
Antibody-drug conjugate (ADC) (49)
Approvals (4414)
Artificial intelligence (55)
Autoimmune disease (9)
Automation (4)
Bankruptcy (28)
Best Places to Work (2191)
BIOSECURE Act (16)
Biosimilars (85)
Biotechnology (31)
Bladder cancer (27)
Brain cancer (7)
Breast cancer (66)
Cancer (629)
Cardiovascular disease (26)
Career advice (125)
Career pathing (3)
CAR-T (22)
Cell therapy (104)
Cervical cancer (3)
Clinical research (17229)
Collaboration (265)
Compensation (51)
Complete response letters (11)
COVID-19 (676)
CRISPR (5)
C-suite (65)
Cystic fibrosis (17)
Data (583)
Denatured (2)
Depression (7)
Diabetes (47)
Diagnostics (1112)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (36)
Drug pricing (25)
Drug shortages (1)
Duchenne muscular dystrophy (34)
Earnings (15833)
Editorial (6)
Employer branding (3)
Employer resources (10)
Events (17843)
Executive appointments (164)
FDA (4846)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (198)
Gene editing (26)
Generative AI (6)
Gene therapy (98)
GLP-1 (141)
Government (1468)
Grass and pollen (2)
Guidances (14)
Healthcare (2893)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (43)
Indications (12)
Infectious disease (719)
Inflammatory bowel disease (56)
Inflation Reduction Act (4)
Influenza (21)
Intellectual property (26)
Interviews (11)
IPO (3206)
IRA (13)
Job creations (603)
Job search strategy (121)
Kidney cancer (2)
Labor market (2)
Layoffs (60)
Leadership (1)
Legal (1448)
Liver cancer (28)
Lung cancer (100)
Lymphoma (40)
Machine learning (1)
Management (2)
Manufacturing (132)
MASH (17)
Medical device (2189)
Medtech (2191)
Mergers & acquisitions (4971)
Metabolic disorders (119)
Multiple sclerosis (21)
NASH (3)
Neurodegenerative disease (21)
Neuropsychiatric disorders (1)
Neuroscience (449)
NextGen: Class of 2025 (897)
Non-profit (410)
Northern California (579)
Now hiring (11)
Obesity (46)
Opinion (48)
Ovarian cancer (30)
Pain (13)
Pancreatic cancer (20)
Parkinson's disease (22)
Partnered (5)
Patents (49)
Patient recruitment (23)
Peanut (21)
People (12192)
Pharmaceutical (14)
Pharmacy benefit managers (2)
Phase I (5339)
Phase II (7203)
Phase III (6328)
Pipeline (392)
Policy (52)
Postmarket research (514)
Preclinical (2026)
Press Release (66)
Prostate cancer (24)
Psychedelics (5)
Radiopharmaceuticals (59)
Rare diseases (95)
Real estate (1408)
Recruiting (4)
Regulatory (6848)
Reports (12)
Research institute (461)
Resumes & cover letters (12)
RNA editing (1)
RSV (11)
Schizophrenia (15)
Series A (46)
Series B (19)
Service/supplier (4)
Sickle cell disease (8)
Southern California (619)
Special edition (3)
Spinal muscular atrophy (24)
Sponsored (9)
Startups (931)
State (1)
Stomach cancer (4)
Supply chain (17)
Tariffs (11)
The Weekly (4)
United States (5180)
Vaccines (204)
Venture capitalists (7)
Weight loss (18)
Women's health (4)
Date
Today (21)
Last 7 days (170)
Last 30 days (687)
Last 365 days (8426)
2025 (2613)
2024 (8906)
2023 (9902)
2022 (14512)
2021 (14559)
2020 (13047)
2019 (9072)
2018 (7026)
2017 (8087)
2016 (7297)
2015 (8785)
2014 (6389)
2013 (5138)
2012 (5445)
2011 (5710)
2010 (4996)
Location
Africa (161)
Alabama (12)
Alaska (1)
Arizona (20)
Arkansas (2)
Asia (25276)
Australia (3057)
California (1419)
Canada (418)
China (274)
Colorado (37)
Connecticut (37)
Delaware (42)
Europe (24222)
Florida (156)
Georgia (25)
Idaho (13)
Illinois (66)
India (16)
Indiana (43)
Iowa (2)
Japan (91)
Kansas (8)
Kentucky (9)
Louisiana (3)
Maine (9)
Maryland (370)
Massachusetts (978)
Michigan (26)
Minnesota (71)
Mississippi (1)
Missouri (18)
Montana (5)
Nebraska (2)
Nevada (5)
New Hampshire (3)
New Jersey (611)
New Mexico (4)
New York (415)
North Carolina (243)
North Dakota (7)
Northern California (579)
Ohio (41)
Oklahoma (7)
Oregon (4)
Pennsylvania (235)
Puerto Rico (1)
Rhode Island (5)
South America (227)
South Carolina (2)
Southern California (619)
Tennessee (3)
Texas (174)
Utah (36)
Virginia (41)
Washington D.C. (8)
Washington State (107)
Wisconsin (12)
152,139 Results for "cobra biologics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to share additional data from its diagnostic 64Cu-SAR-bisPSMA trial, COBRA.
March 8, 2024
·
11 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Press Releases
Polyrizon Ltd. Announces $17.0 Million Private Placement
April 1, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Bora Biologics Unveils Cutting-Edge Innovations at Festival of Biologics 2025
April 17, 2025
·
2 min read
Biotech Bay
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today issued the following statement about the closure of COBRA, a minimum residual disease (MRD) study.
September 1, 2023
·
3 min read
1 of 15,214
Next
